Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD |
2018-08-14 |
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures |
2018-08-10 |
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP |
2018-08-10 |
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience |
2018-08-10 |
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group |
2018-08-10 |
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP |
2018-08-10 |
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures |
2018-08-10 |
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund |
2018-08-10 |
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures |
2018-08-10 |
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP |
2018-08-10 |
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV |
2018-08-10 |
Akouos–Novartis: investment, 201808 financing round Series A totalling $50m incl new co-investor Novartis Venture Fund |
2018-08-07 |
Akouos–SEVERAL: investment, 201808 financing round Series A $50m co-led by existing investors 5AM Ventures + NEA |
2018-08-07 |
United Kingdom (govt)–Bruker: NMR technology, 201808 supply £20m NMR technology to 8 UK universities funded by EPSRC + BBSRC + MRC +NERC |
2018-08-06 |
Univ Birmingham–Bruker: NMR spectrometer, 201808 supply 1GHz NMR spectrometer |
2018-08-06 |
Univ Warwick–Bruker: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer |
2018-08-06 |
Arsanis–Gates Foundation: grant, 201808 grant $1.1.m for preclinical development of ASN500 programme |
2018-08-01 |
Miraca–Qiagen: molecular companion diagnostics, 201808– collab with SRL to introduce of CDx tests in Japan in line with respective drug approvals |
2018-08-01 |
Bayer–Leo Pharma: investment, 201807–201907 acquisition of global prescription dermatology business of Bayer |
2018-07-31 |
B&W Tek–Metrohm: investment, 201807 acquisition €na of B&W Tek LLC + several overseas subisidiaries |
2018-07-27 |
Biocrates–MC Services: public relations, 201807 service existent by MC Services |
2018-07-25 |
Nabriva–SEVERAL: investment, 201807 public offering $50m net $46.1m with 18.2m ordinary shares at $2.75/share |
2018-07-25 |
Innovative Medicines Initiative–Agena Bioscience: MassARRAY Technology, 201807– collab use of MassArray system in CANCER-ID Consortium |
2018-07-24 |
Zavante Therapeutics–Nabriva: investment, 201807 acquisition upfront 8.2m Nabriva ordinary shares (=19.9% shareholding) + $97.5m milestones |
2018-07-24 |
SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m |
2018-07-20 |
Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding |
2018-07-19 |
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services |
2018-07-18 |
Agilent–AMETEK: FTIR analyzer, 201807 collab developm + manufacturing Miniscan IR LOG FTIR analyzer for in-field oil/grease analysis |
2018-07-18 |
Beiersdorf–S-Biomedic: skin microbiomics, 201807– collaboration |
2018-07-18 |
DCPrime–Glycotope: cancer immunotherapy, 201807– license + collab agreement research new approaches to solid tumours |
2018-07-18 |
S-Biomedic–Beiersdorf: investment, 201807 financing round Series A 1st closing totalling €2m incl lead investor Beiersdorf AG |
2018-07-18 |
S-Biomedic–JnJ: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor JnJ Innovation JJDC |
2018-07-18 |
S-Biomedic–SEVERAL: investment, 201807 financing round Series A 1st closing €2m led by Beiersdorf + incl investiere.ch + JnJ Innovation JJDC |
2018-07-18 |
S-Biomedic–Verve Capital Partners: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor investiere.ch |
2018-07-18 |
B Braun–CeGaT: personalised medicine, 201807 collab establishment of B Braun Precision Medicine Technology (Shanghai) Ltd |
2018-07-17 |
CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT |
2018-07-17 |
Labfolder–NEC: information technology, 201807– collab €na combining Labfolder s/w with NEC hardware for scalable data storage solutions |
2018-07-17 |
Mosa Meat–Bell Food: investment, 201807 financing round Series A totalling €7.5m incl co-lead investor Bell Food Group |
2018-07-17 |
Mosa Meat–Glass Wall Syndicate: investment, 201807 financing round Series A totalling €7.5m incl co-investor Glass Wall Syndicate |
2018-07-17 |
Mosa Meat–Merck (DE): investment, 201807 financing round Series A totalling €7.5m incl co-lead investor M Ventures |
2018-07-17 |
Mosa Meat–SEVERAL: investment, 201807 financing round Series A €7.5m co-led by M Ventures + Bell Food Group |
2018-07-17 |
Polares Medical–Decheng Capital: investment, 201807 financing round totalling $25m incl lead investor Decheng Capital |
2018-07-17 |
Polares Medical–Earlybird: investment, 201807 financing round totalling $25m incl co-investor Earlybird Venture Capital Berlin |
2018-07-17 |
Polares Medical–Endeavour Vision: investment, 201807 financing round totalling $25m incl co-investor Endeavour Vision |
2018-07-17 |
Polares Medical–IDO Investments: investment, 201807 financing round totalling $25m incl co-investor IDO Investments |
2018-07-17 |
Polares Medical–SEVERAL: investment, 201807 financing round $25m led by Decheng Capital |
2018-07-17 |
Polares Medical–Wellington Partners: investment, 201807 financing round totalling $25m incl co-investor Wellington Partners |
2018-07-17 |
Roche–Shionogi: virostatic agent, 201807 license to baloxavir marboxil excl ww without JP + TW to Roche existent |
2018-07-17 |
Holtzbrinck–Scott Partnership: public relations, 201807– supply service marcom for BioData |
2018-07-16 |
Genmab–Immatics: cancer immunotherapy, 201807– researc collab + excl license to targets for biospecific I-O drugs $54m upfront + $550m milestones |
2018-07-12 |
JPK Instruments–Bruker: investment, 201807 acquisition €na of JPK by Bruker |
2018-07-12 |
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser |
2018-07-12 |
Forbion–SEVERAL: investment, 201807 first close €270m of Forbion IV fund |
2018-07-11 |
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC |
2018-07-10 |
BioNTech–Roivant: LNP technology, 201807– license excl to apply Genevant’s LNP delivery technology to 5 of BioNTech’s oncology programs |
2018-07-10 |
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic |
2018-07-10 |
BioNTech–Westwicke Partners: public relations, 201807 service existent US IR by Westwicke Partners |
2018-07-10 |
Pionyr Immunotherapeutics–Minapharm: biopharma production, 201807– supply service cell line + process dev + prod of 2nd therap antibody by ProBioGen |
2018-07-10 |
Roivant–BioNTech: mRNA therapeutics, 201807– collab strategic partnership to develop 5 products for rare disease with Genevant |
2018-07-10 |
Boehringer–MabVax Therapeutics: antibody cancer drug, 201807 acquisition all rights to preclinical antibody program for solid tumours |
2018-07-09 |
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines |
2018-07-05 |
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines |
2018-07-05 |
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines |
2018-07-05 |
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines |
2018-07-05 |
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines |
2018-07-05 |
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines |
2018-07-05 |
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd |
2018-07-04 |
Lactotronic–Bruker: investment, 201807 acquisition €na of Lactotronic BV by Bruker |
2018-07-03 |
Inveox–SEVERAL: investment, 201807c 2nd financing round €5m from four founding business angels |
2018-07-01 |
Novartis–France (govt): cell therapy contract manufacturing, 201807– supply production CAR-T cell therapies incl Kymriah by CellforCure |
2018-07-01 |
NBE Therapeutics–Novo Group: investment, 201806 financing round Series B CHF20m extension by Novo Holdings bringing total Series B to CHF40m |
2018-06-28 |
Roper Technologies–Thermo Fisher: investment, 201806– acquisition $925m in cash of Gatan Inc from Roper Technologies by Thermo Fisher |
2018-06-28 |
Bruker–Cytosurge: cell analysis technology, 201806 collab product integration FluidFM techn on BioScope Resolve AMF for single cell analysis |
2018-06-27 |
Nouscom–Minapharm: cell line, 201806– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines |
2018-06-26 |
Exosome Diagnostics–Bio-Techne: investment, 201806– acquisition $250m cash + $325m milestones of Exosome Dx by Bio-Techne ANNOUNCED |
2018-06-25 |
Exosome Diagnostics–Goodwin Procter: legal services, 201806 supply service legal counsel with regard to acquisition of Exosome Dx by Bio-Techne Corp |
2018-06-25 |
Exosome Diagnostics–Moelis: financial services, 201806 supply service financial advisor with regard to acquisition of Exosome Dx by Bio-Techne Corp |
2018-06-25 |
Univ Missouri–Bruker: mass spectrometer, 201806 supply existent timsTOF Pro system at Univ of Missouri in Columbia MO |
2018-06-25 |
Evonik–BRAIN: industrial biotechnology, 201806– collab with CyPlus to develop products for global mining industry |
2018-06-20 |
iTeos Therapeutics–6 Dimensions Capital: investment, 201806 financing round Series B totalling €64m incl new + co-investor 6 Dimensions Capital |
2018-06-20 |
iTeos Therapeutics–Belgium (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SFPI |
2018-06-20 |
iTeos Therapeutics–Curative Ventures: investment, 201806 financing round Series B totalling €64m incl new + co-investor Curative Ventures |
2018-06-20 |
iTeos Therapeutics–Fund+: investment, 201806 financing round Series B totalling €64m incl existing + co-investor Fund+ |
2018-06-20 |
iTeos Therapeutics–HBM: investment, 201806 financing round Series B totalling €64m incl new + co-investor HBM Partners |
2018-06-20 |
iTeos Therapeutics–MPM Capital: investment, 201806 financing round Series B totalling €64m incl new + lead investor MPM Capital |
2018-06-20 |
iTeos Therapeutics–SEVERAL: investment, 201806 financing round Series B €64m led by MPM Capital |
2018-06-20 |
iTeos Therapeutics–Univ Leuven: investment, 201806 financing round Series B totalling €64m incl existing + co-investor VIVES II |
2018-06-20 |
iTeos Therapeutics–Wallonia (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SRIW |
2018-06-20 |
TG Therapeutics–Novimmune: bispecific antibody, 201806– collab + excl license option ww for CD47/CD19 antibody NI-1701 (TG-1801) |
2018-06-20 |
Foundation Medicine–Roche: investment, 201806–201807 acquisition all remaining shares for $2.4b in cash at $137/share |
2018-06-19 |
UgiSense–SEVERAL: investment, 201806 second financing round |
2018-06-19 |
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics |
2018-06-16 |
Noxxon–SEVERAL: credit, 201806– convertible bond €380k from existing investors |
2018-06-15 |
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec |
2018-06-15 |
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share |
2018-06-14 |
Andrew Alliance–Omega Funds: investment, 201806 financing round Series C totalling $14m incl Omega Funds |
2018-06-12 |
Andrew Alliance–SEVERAL: investment, 201806 financing round Series C $14m incl Tecan + Waters + Inpeco + Rancilio Cube + Sam Eletr + Omega Funds |
2018-06-12 |
Andrew Alliance–Tecan: investment, 201806 financing round Series C totalling $14m incl Tecan Group |
2018-06-12 |
Andrew Alliance–Waters: investment, 201806 financing round Series C totalling $14m incl Waters Corp |
2018-06-12 |
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings |
2018-06-12 |